Soooo when is it our turn?We all know of the Valens purchase from earlier this week but old news along with it was the analyst downgrade of Medipharm as well a week ago. See below.
Looks like we're running out of compeition in the space. Hopefully that helps us stand out and brings with itr some inbound leads to the sales and marketing teams fopr more bulk orders.
https://finance.yahoo.com/news/analysts-just-made-major-revision-101201815.html